August 18, 2024Open Access

Clinical profile, associated events and safety of vericiguat in a real‐world cohort: The VERITA study

Key Points

Key points are not available for this paper at this time.

Abstract

The aim of this study was to determine the clinical profile, associated events and safety of vericiguat in a real-world cohort of patients with heart failure with reduced ejection fraction (HFrEF).

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Mario Galván Ruíz

Hospital Universitario de Gran Canaria Doctor Negrín

Miguel Fernández de Sanmamed Girón

Hospital Universitario de Gran Canaria Doctor Negrín

María del Val Groba Marco

Hospital Universitario de Gran Canaria Doctor Negrín

Journals

ESC Heart Failure

Actions

Institutions

Universidad de Las Palmas de Gran Canaria

Hospital Universitario de Gran Canaria Doctor Negrín

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Clinical profile, associated events and safety of vericiguat in a real‐world cohort: The VERITA study

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study